 |
|
Evidence for Cerebellar-Frontal Subsystem Changes in Children Treated With Intrathecal Chemotherapy for Leukemia
Enhanced Data Analysis Using an Effect Size Model
Paul G. Lesnik, MS;
Kristina T. Ciesielski, PhD;
Blaine L. Hart, MD;
Edward C. Benzel, MD;
John A. Sanders, PhD
Arch Neurol. 1998;55:1561-1568.
Background Following brain insult in early childhood, the later maturing neocerebellum and frontal lobes frequently show abnormalities.
Objective To investigate the morphologic characteristics and function of a proposed cerebellar-frontal subsystem in children treated for acute lymphoblastic leukemia (ALL) with intrathecal methotrexate using quantitative magnetic resonance imaging, neuropsychological measures, nonlinear multiple regression analysis, and a statistical effect size model that augments interpretive validity of nonsignificant statistical findings, particularly from small sample size studies.
Design Comparison and relationship of magnetic resonance imaging morphometry of cerebellar lobuli I-V and VI-VII and prefrontal cortices, and performance on 5 neuropsychological tests assessing visual-spatial attention, short-term memory, and visuomotor organization and coordination between childhood survivors of ALL and a matched control group.
Participants Ten childhood survivors of ALL treated between 1982 and 1989 with standard 3-year intrathecal chemotherapy, and matched control subjects.
Main Outcome Measures Morphometric results of cerebellar lobuli I-V and VI-VII and prefrontal cortices, and results of Trail-Making Tests, Rey-Osterreith Complex Figure Test, WISC-III Coding.
Results Significant effect size model values for outcome measures in the ALL group support deficits in lobuli VI-VII and prefrontal cortices, and neuropsychological performance. Multiple regression analysis results were consistent with hypothesized involvement of a cerebellar-frontal brain subsystem.
Conclusion Treatment of children with ALL with intrathecal methotrexate before 5 years of age has structural and functional effects on the developing neocerebellar-frontal subsystem.
From the Clinical Neuroscience Laboratory, Department of Psychology (Mr Lesnik and Dr Ciesielski), Department of Radiology, Health Sciences Center (Dr Hart), and Department of Neurosurgery, Health Sciences Center (Dr Benzel), The University of New Mexico, Albuquerque; and Neuroimaging Section, Albuquerque Veterans Affairs Medical Center (Dr Sanders).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Executive Function, Coping, and Behavior in Survivors of Childhood Acute Lymphocytic Leukemia
Campbell et al.
J Pediatr Psychol 2009;34:317-327.
ABSTRACT
| FULL TEXT
Reduced Frontal White Matter Volume in Long-Term Childhood Leukemia Survivors: A Voxel-Based Morphometry Study
Carey et al.
Am. J. Neuroradiol. 2008;29:792-797.
ABSTRACT
| FULL TEXT
Scholarly Literature Review: Management of Neurocognitive Late Effects with Stimulant Medication
Daly and Brown
J Pediatr Psychol 2007;32:1111-1126.
ABSTRACT
| FULL TEXT
Motor and Perceptual Timing Deficits Among Survivors of Childhood Leukemia
Mark Mahone et al.
J Pediatr Psychol 2007;32:918-925.
ABSTRACT
| FULL TEXT
Oxidative Changes in Cerebral Spinal Fluid Phosphatidylcholine during Treatment for Acute Lymphoblastic Leukemia
Miketova et al.
Biol Res Nurs 2005;6:187-195.
ABSTRACT
Long-term sequelae in children after cerebellar astrocytoma surgery
Aarsen et al.
Neurology 2004;62:1311-1316.
ABSTRACT
| FULL TEXT
Intrathecal methotrexate affects cognitive function in children with medulloblastoma
Riva et al.
Neurology 2002;59:48-53.
ABSTRACT
| FULL TEXT
|
